Efficacy of radiolabelled PD-L1-targeted nanobody in predicting and evaluating the combined immunotherapy and chemotherapy for resectable non-small cell lung cancer.
Saved in:
| Title: | Efficacy of radiolabelled PD-L1-targeted nanobody in predicting and evaluating the combined immunotherapy and chemotherapy for resectable non-small cell lung cancer. |
|---|---|
| Authors: | Zhou, Xin1 (AUTHOR), Yan, Shi2 (AUTHOR), Ma, Xiaopan1,3 (AUTHOR), Zhu, Hua1 (AUTHOR), Liu, Bing2 (AUTHOR), Yang, Xin4 (AUTHOR), Jia, Bing5 (AUTHOR) jiabing@bjmu.edu.cn, Yang, Zhi1 (AUTHOR) pekyz@163.com, Wu, Nan2 (AUTHOR) nanwu@bjmu.edu.cn, Li, Nan1 (AUTHOR) rainbow6283@sina.com |
| Source: | European Journal of Nuclear Medicine & Molecular Imaging. Jun2025, Vol. 52 Issue 7, p2343-2354. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
